Alejandro Sánchez Alvarado
Vilcek Foundation Awards $100,000 Prize in Biomedical Science to Alejandro Sánchez Alvarado
February 22, 2023 10:45 ET | The Vilcek Foundation
NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- For his contributions to the field of regeneration, Alejandro Sánchez Alvarado receives the Vilcek Prize in Biomedical Science. The Vilcek Prize in...
Terra Madre Salone del Gusto is back in Turin and in Piedmont
Terra Madre Salone del Gusto is Back, Turin and Piedmont in the Spotlight
September 26, 2022 05:36 ET | Terra Madre Salone del Gusto
TURIN, Italy, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Terra Madre Salone del Gusto is back in Turin and in Piedmont. From 22 to 26 September the former industrial spaces of Parco Dora are hosting The...
Pantone_ClimateFirstBank-Logo-Stacked-White-Registered.png
Climate First Bank Celebrates One Year of Operation
June 15, 2022 09:27 ET | Climate First Bank
ST. PETERSBURG, Fla., June 15, 2022 (GLOBE NEWSWIRE) -- Climate First Bank, a full-service FDIC-insured commercial bank focused on environmental sustainability, celebrates one year of operation this...
The Kin DAO
Primordia DAO Launches to Establish 100 DAOs for Positive Social Change in 2022 With Real-World Communities From Around the World
June 02, 2022 13:16 ET | The Kin DAO
SAN FRANCISCO, June 02, 2022 (GLOBE NEWSWIRE) -- The Kin DAO (DAO is a decentralized autonomous organization) today announced the launch of its Primordia DAO, a year-long project DAO to be...
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
June 01, 2022 09:00 ET | Recardio Inc.
SAN FRANCISCO, June 01, 2022 (GLOBE NEWSWIRE) -- Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin along with data suggesting potential positive...
Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
May 23, 2022 14:00 ET | Recardio Inc.
SAN FRANCISCO, May 23, 2022 (GLOBE NEWSWIRE) -- Entitled "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptinin Combination with Filgrastim in Early...
Pantone_ClimateFirstBank-Logo-Stacked-White-Registered.png
Climate First Bank’s Regeneration Checking Account Now Available
February 10, 2022 10:00 ET | Climate First Bank
ST. PETERSBURG, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Climate First Bank, a FDIC-insured commercial bank with a global mission to halt and reverse the climate crisis, today announces its...
Pantone_ClimateFirstBank-Logo-Stacked-White-Registered.png
Climate First Bank Joins Forces with Project Regeneration to End the Climate Crisis
December 16, 2021 09:00 ET | Climate First Bank
ST. PETERSBURG, Fla., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Values-based community bank Climate First Bank has partnered with Project Regeneration to develop a one-of-a-kind checking account that will...
Surrozen Logo FINAL Large-1.png
Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO)
July 09, 2021 08:00 ET | Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., July 09, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, announced...
RenovaCare Clinical Trial to Start at U.S. Burn Centers
RenovaCare Clinical Trial to Start at U.S. Burn Centers
June 07, 2021 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United...